Abstract: The specification generally relates to compounds of Formula (I): and pharmaceutically acceptable salts thereof, where R1, A1, A2 and A3 have any of the meanings defined herein. The specification also relates to the use of such compounds and salts thereof to treat or prevent DNA-PK mediated disease, including cancer. The specification further relates to pharmaceutical compositions comprising such compounds and salts; kits comprising such compounds and salts; methods of manufacture of such compounds and salts; intermediates useful in the manufacture of such compounds and salts; and to methods of treating DNA-PK mediated disease, including cancer, using such compounds and salts.

Abstract: A system for the treatment of CMP wastewater, including wastewater from a copper CMP process. The wastewater treatment system includes a coagulant supply tank from which an FSC polymer coagulant is directed into a reaction tank that separately receives the untreated wastewater. The coagulant may be mixed with the untreated wastewater in selected ratios to provide a desired dosing quantity of the coagulant in the reaction tank. As the wastewater and the FSC polymer coagulant are mixed in the reaction tank, the coagulant flocs the slurry chemicals in the wastewater and removes the chemicals from solution in the wastewater as a precipitate before the wastewater is directed to a clarifier. The clarifier separates the flocked precipitate from the wastewater, and the flocked particles settle on the bottom of the clarifier to form a sludge. The sludge is re-distributed back into the clarifier to coagulate inert particles in the wastewater.

Abstract: A system for the treatment of CMP wastewater, including wastewater from a copper CMP process. The wastewater treatment system includes a coagulant supply tank from which an FSC polymer coagulant is directed into a reaction tank that separately receives the untreated wastewater. The coagulant may be mixed with the untreated wastewater in selected ratios to provide a desired dosing quantity of the coagulant in the reaction tank. As the wastewater and the FSC polymer coagulant are mixed in the reaction tank, the coagulant flocs the slurry chemicals in the wastewater and removes the chemicals from solution in the wastewater as a precipitate before the wastewater is directed to a clarifier. The clarifier separates the flocked precipitate from the wastewater, and the flocked particles settle on the bottom of the clarifier to form a sludge. The sludge is re-distributed back into the clarifier to coagulate inert particles in the wastewater.